Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne-Marie Cleton-Jansen

Showing results (41-50 of 127) with videos related to

Pageof 13
Sort By:
Clinical Sarcoma Research|August 31, 2018
Low-grade central fibroblastic osteosarcoma may be differentiated from its mimicker desmoplastic fibroma by genetic analysisWangzhao Song, Eva van den Berg, Thomas C Kwee, et al.
Thrombosis and Haemostasis|January 15, 2016
Tissue factor associates with survival and regulates tumour progression in osteosarcomaChris Tieken, Michiel C Verboom, Wolfram Ruf, et al.
Cancer Letters|November 12, 2017
IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograftSara R Martins-Neves, Daniela I Paiva-Oliveira, Carlos Fontes-Ribeiro, et al.
The American Journal of Pathology|January 31, 2009
Aberrant heparan sulfate proteoglycan localization, despite normal exostosin, in central chondrosarcomaYvonne M Schrage, Liesbeth Hameetman, Karoly Szuhai, et al.
The Journal of Pathology|September 5, 2002
Functional allelic loss detected at the protein level in archival human tumours using allele-specific E-cadherin monoclonal antibodiesKarl-Friedrich Becker, Elisabeth Kremmer, Manfred Eulitz, et al.
The American Journal of Pathology|March 26, 2003
Molecular genetic evidence for monoclonal origin of bilateral ovarian serous borderline tumorsNathalie L G Sieben, Sandra M Kolkman-Uljee, Adrienne M Flanagan, et al.
The Journal of Pathology|July 12, 2005
cDNA expression profiling of chondrosarcomas: Ollier disease resembles solitary tumours and alteration in genes coding for components of energy metabolism occurs with increasing gradeLeida B Rozeman, Liesbeth Hameetman, Tom van Wezel, et al.
Virchows Archiv : an International Journal of Pathology|December 11, 2012
Mutations affecting BRAF, EGFR, PIK3CA, and KRAS are not associated with sporadic vestibular schwannomasMaurits de Vries, Inge Briaire-de Bruijn, Anne-Marie Cleton-Jansen, et al.
Journal of Cellular and Molecular Medicine|July 16, 2008
Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitroYvonne M Schrage, Suzanne Lam, Aart G Jochemsen, et al.
Cancer|June 15, 2007
The role of noncartilage-specific molecules in differentiation of cartilaginous tumors: lessons from chondroblastoma and chondromyxoid fibromaSalvatore Romeo, Jan Oosting, Leida B Rozeman, et al.
Pageof 13

Showing results (41-50 of 127) with videos related to

Sort By:
Pageof 13
Clinical Sarcoma Research|August 31, 2018
Low-grade central fibroblastic osteosarcoma may be differentiated from its mimicker desmoplastic fibroma by genetic analysisWangzhao Song, Eva van den Berg, Thomas C Kwee, et al.
Thrombosis and Haemostasis|January 15, 2016
Tissue factor associates with survival and regulates tumour progression in osteosarcomaChris Tieken, Michiel C Verboom, Wolfram Ruf, et al.
Cancer Letters|November 12, 2017
IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograftSara R Martins-Neves, Daniela I Paiva-Oliveira, Carlos Fontes-Ribeiro, et al.
The American Journal of Pathology|January 31, 2009
Aberrant heparan sulfate proteoglycan localization, despite normal exostosin, in central chondrosarcomaYvonne M Schrage, Liesbeth Hameetman, Karoly Szuhai, et al.
The Journal of Pathology|September 5, 2002
Functional allelic loss detected at the protein level in archival human tumours using allele-specific E-cadherin monoclonal antibodiesKarl-Friedrich Becker, Elisabeth Kremmer, Manfred Eulitz, et al.
The American Journal of Pathology|March 26, 2003
Molecular genetic evidence for monoclonal origin of bilateral ovarian serous borderline tumorsNathalie L G Sieben, Sandra M Kolkman-Uljee, Adrienne M Flanagan, et al.
The Journal of Pathology|July 12, 2005
cDNA expression profiling of chondrosarcomas: Ollier disease resembles solitary tumours and alteration in genes coding for components of energy metabolism occurs with increasing gradeLeida B Rozeman, Liesbeth Hameetman, Tom van Wezel, et al.
Virchows Archiv : an International Journal of Pathology|December 11, 2012
Mutations affecting BRAF, EGFR, PIK3CA, and KRAS are not associated with sporadic vestibular schwannomasMaurits de Vries, Inge Briaire-de Bruijn, Anne-Marie Cleton-Jansen, et al.
Journal of Cellular and Molecular Medicine|July 16, 2008
Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitroYvonne M Schrage, Suzanne Lam, Aart G Jochemsen, et al.
Cancer|June 15, 2007
The role of noncartilage-specific molecules in differentiation of cartilaginous tumors: lessons from chondroblastoma and chondromyxoid fibromaSalvatore Romeo, Jan Oosting, Leida B Rozeman, et al.
Pageof 13